Roche throws HIV blindness drug Valcyte into patent pool

Carly Helfand

has signed an agreement with the Medicines to surrender 's patent and make the available in developing countries by slashing costs by up to 90%.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS